JP2024540108A5 - - Google Patents

Info

Publication number
JP2024540108A5
JP2024540108A5 JP2024525411A JP2024525411A JP2024540108A5 JP 2024540108 A5 JP2024540108 A5 JP 2024540108A5 JP 2024525411 A JP2024525411 A JP 2024525411A JP 2024525411 A JP2024525411 A JP 2024525411A JP 2024540108 A5 JP2024540108 A5 JP 2024540108A5
Authority
JP
Japan
Prior art keywords
lipid
compound
independently
lipid nanoparticles
mol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024525411A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024540108A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/080581 external-priority patent/WO2023078950A1/en
Publication of JP2024540108A publication Critical patent/JP2024540108A/ja
Publication of JP2024540108A5 publication Critical patent/JP2024540108A5/ja
Pending legal-status Critical Current

Links

JP2024525411A 2021-11-02 2022-11-02 オリゴヌクレオチド送達のための脂質ナノ粒子 Pending JP2024540108A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP21205904.2 2021-11-02
EP21205904 2021-11-02
EP22179399 2022-06-16
EP22179399.5 2022-06-16
PCT/EP2022/080581 WO2023078950A1 (en) 2021-11-02 2022-11-02 Lipid nanoparticles for oligonucleotide delivery

Publications (2)

Publication Number Publication Date
JP2024540108A JP2024540108A (ja) 2024-10-31
JP2024540108A5 true JP2024540108A5 (cg-RX-API-DMAC7.html) 2025-10-31

Family

ID=84364268

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024525411A Pending JP2024540108A (ja) 2021-11-02 2022-11-02 オリゴヌクレオチド送達のための脂質ナノ粒子

Country Status (14)

Country Link
US (1) US20250236599A1 (cg-RX-API-DMAC7.html)
EP (2) EP4426270B1 (cg-RX-API-DMAC7.html)
JP (1) JP2024540108A (cg-RX-API-DMAC7.html)
KR (1) KR20240099377A (cg-RX-API-DMAC7.html)
AU (1) AU2022381463A1 (cg-RX-API-DMAC7.html)
CA (1) CA3236653A1 (cg-RX-API-DMAC7.html)
DK (1) DK4426270T3 (cg-RX-API-DMAC7.html)
ES (1) ES3042660T3 (cg-RX-API-DMAC7.html)
FI (1) FI4426270T3 (cg-RX-API-DMAC7.html)
IL (1) IL312432B2 (cg-RX-API-DMAC7.html)
MX (1) MX2024005109A (cg-RX-API-DMAC7.html)
PL (1) PL4426270T3 (cg-RX-API-DMAC7.html)
WO (1) WO2023078950A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202403360B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12678515B2 (en) 2015-12-30 2026-07-14 Acuitas Therapeutics, Inc. Lipids and lipid nanoparticle formulations for delivery of nucleic acids
US12491261B2 (en) 2016-10-26 2025-12-09 Acuitas Therapeutics, Inc. Lipid nanoparticle formulations
CA3116576A1 (en) 2018-10-18 2020-04-23 Acuitas Therapeutics, Inc. Lipids for lipid nanoparticle delivery of active agents
JP2025538515A (ja) * 2022-11-25 2025-11-28 艾斯拓康医薬科技(北京)有限公司 イオン化脂質及びその応用
JP2025534494A (ja) * 2022-12-23 2025-10-15 グリーン・クロス・コーポレイション イオン化可能な脂質及びその使用
CN119219539A (zh) * 2023-06-29 2024-12-31 艾斯拓康医药科技(北京)有限公司 可离子化脂质及其应用
WO2025088152A1 (en) 2023-10-27 2025-05-01 Ziphius Nv MODIFIED 5'UTRs
US12599560B2 (en) 2023-11-02 2026-04-14 Longuide Biopharma Corporation Lipids and lipid nanoparticle formulations
AU2024381228A1 (en) 2023-11-13 2026-05-28 Ziphius Nv MODIFIED ALPHAVIRAL nsP3
WO2025128696A1 (en) * 2023-12-12 2025-06-19 Acuitas Therapeutics, Inc. Cationic lipid compounds for use in lipid nanoparticles
WO2025255534A1 (en) * 2024-06-07 2025-12-11 Innovac Therapeutics Hk Limited Diol-based novel ionizable lipids and their uses thereof
WO2026112559A1 (en) * 2024-11-25 2026-05-28 Genzyme Corporation Ionizable cationic lipids and lipid nanoparticles, and methods of synthesis and use thereof
WO2026117525A1 (en) * 2024-11-26 2026-06-04 Flagship Pioneering Innovations Vii, Llc Ionizable lipidoid compositions and therapeutic uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451592B1 (en) 1996-04-05 2002-09-17 Chiron Corporation Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
PT1751289E (pt) 2004-05-18 2009-03-31 Alphavax Inc Vectores de alfavirais derivados da tc-83, partículas e métodos
US7332322B2 (en) 2004-09-14 2008-02-19 Ilya Frolov Venezuelan equine encephalitis virus replicons with adaptive mutations in the genome and uses thereof
WO2014028487A1 (en) * 2012-08-13 2014-02-20 Massachusetts Institute Of Technology Amine-containing lipidoids and uses thereof
CA2953341C (en) * 2014-06-25 2023-01-24 Acuitas Therapeutics Inc. Lipids and lipid nanoparticle formulations for delivery of nucleic acids
KR20190093816A (ko) * 2016-10-26 2019-08-26 큐어백 아게 지질 나노입자 mRNA 백신
EP3638678B1 (en) * 2017-06-14 2025-12-03 ModernaTX, Inc. Compounds and compositions for intracellular delivery of agents

Similar Documents

Publication Publication Date Title
JP2024540101A5 (cg-RX-API-DMAC7.html)
FI4426270T3 (fi) Lipidi-nanopartikkelit oligonukleotidien kuljetusta varten
JP2025041652A5 (cg-RX-API-DMAC7.html)
JP6592458B2 (ja) カチオン性脂質
US7709449B2 (en) Nucleic acid-based compounds and methods of use thereof
ES2924806T3 (es) Análogos de 4'-fosfato y oligonucleótidos que comprenden el mismo
JP2021535226A5 (cg-RX-API-DMAC7.html)
JP2021535227A5 (cg-RX-API-DMAC7.html)
WO2007095976A2 (de) Adjuvanz in form einer lipid-modifizierten nukleinsäure
JP2019525918A5 (cg-RX-API-DMAC7.html)
EA022757B1 (ru) МОТИВЫ ХИМИЧЕСКИХ МОДИФИКАЦИЙ ДЛЯ ИНГИБИТОРОВ И МИМЕТИКОВ мкРНК
JP2023534206A5 (cg-RX-API-DMAC7.html)
JP2015521626A (ja) ロックド核酸モチーフを含むオリゴヌクレオチドベースの阻害剤
JP2022546557A5 (cg-RX-API-DMAC7.html)
JP2022536495A5 (cg-RX-API-DMAC7.html)
JP2020512293A (ja) インフュージョンリアクションを改善するための方法
JP2019527549A5 (cg-RX-API-DMAC7.html)
EP3400008A2 (en) Therapeutic compositions and methods for treating hepatitis b
WO2024019770A1 (en) Methods of making ionizable lipids and lipid nanoparticles for mrna delivery
CN118105357B (zh) 一种鞘内递送制剂及其用途
JP2025038098A (ja) 筋ジストロフィーに対するエクソンスキッピングオリゴマー
CN120359208A (zh) 可电离脂质及其用途
JP7658900B2 (ja) 筋ジストロフィーに対するエクソンスキッピングオリゴマーコンジュゲート
JP2018518167A5 (cg-RX-API-DMAC7.html)
WO2023176822A1 (ja) 化合物および脂質組成物